When was roche diagnostics founded




















The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. The Roche Group, headquartered in Basel, Switzerland, is active in over countries and in employed about 94, people worldwide.

In , Roche invested CHF Genentech, in the United States, is a wholly owned member of the Roche Group. Piper Categories: Hoffmann-La Roche Pharmaceutical companies. Read what you need to know about our industry portal chemeurope.

My watch list my. My watch list My saved searches My saved topics My newsletter Register free of charge. Keep logged in. Cookies deactivated. To use all functions of this page, please activate cookies in your browser.

Login Register. Additional recommended knowledge. Topics A-Z. All topics. To top. About chemeurope. Colorimetry-Software Day Free Trial. Your browser is not current. Microsoft Internet Explorer 6. Your browser does not support JavaScript. To use all the functions on Chemie. DE please activate JavaScript. From very early on, the company was known for producing various vitamin preparations and derivatives. Under the new leadership of chairman, Emil C Barell, Roche experienced an unexpected upsurge spurred by its vitamin production, enabling the return to prosperity possible once more.

In , Roche was the first company to mass produce synthetic vitamin C, under the brand name redoxon. It was following this success that Roche further expanded its strong commitment with the United States. To avoid dependency on vitamins, Roche intensified its pharmaceutical research. The antidepressant, iproniazid, was accidently created by Roche during an experiment intended to create a more efficient drug for tuberculosis.

Iproniazid was withdrawn from the market in the early s, however, due to toxic side-effects. In , Roche introduced the class of tranquilizers known as benzodiazepines, which count valium and rohypnol as its most widely recognised members.

The desired effect of these benzodiazepines was that they sedated patients without drowsiness. Between and , Roche expanded its business further into the spectrum of healthcare. However on July 10th , Roche experienced a major setback when there was an accident at a chemical factory in Seveso, Italy, owned by a subsidiary of the company. This accident caused a large dioxin contamination in the surrounding communities.



0コメント

  • 1000 / 1000